Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Mullan

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Oncotarget|August 7, 2019
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal cryptLouise R Dutton, Owen P Hoare, Amy M B McCorry, et al.
Nucleic Acids Research|July 19, 2013
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancersNiamh E Buckley, Caoimhe B Nic An tSaoir, Jaine K Blayney, et al.
Oncogene|February 26, 2013
NF-κB is a critical mediator of BRCA1-induced chemoresistanceMary T Harte, Julia J Gorski, Kienan I Savage, et al.
Breast Cancer Research and Treatment|November 3, 2009
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancerJulia J Gorski, Colin R James, Jennifer E Quinn, et al.
Nucleic Acids Research|June 10, 2022
TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancersAlexander J McIntyre, Charlotte Z Angel, James S Smith, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
Histopathology|March 12, 2014
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancerDavid P Boyle, Darragh G McArt, Gareth Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Cancer Research|March 3, 2011
The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancerNiamh E Buckley, Susan J Conlon, Karin Jirstrom, et al.
Journal of the National Cancer Institute|October 7, 2016
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast CancerEileen E Parkes, Steven M Walker, Laura E Taggart, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Oncotarget|August 7, 2019
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal cryptLouise R Dutton, Owen P Hoare, Amy M B McCorry, et al.
Nucleic Acids Research|July 19, 2013
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancersNiamh E Buckley, Caoimhe B Nic An tSaoir, Jaine K Blayney, et al.
Oncogene|February 26, 2013
NF-κB is a critical mediator of BRCA1-induced chemoresistanceMary T Harte, Julia J Gorski, Kienan I Savage, et al.
Breast Cancer Research and Treatment|November 3, 2009
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancerJulia J Gorski, Colin R James, Jennifer E Quinn, et al.
Nucleic Acids Research|June 10, 2022
TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancersAlexander J McIntyre, Charlotte Z Angel, James S Smith, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
Histopathology|March 12, 2014
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancerDavid P Boyle, Darragh G McArt, Gareth Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Cancer Research|March 3, 2011
The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancerNiamh E Buckley, Susan J Conlon, Karin Jirstrom, et al.
Journal of the National Cancer Institute|October 7, 2016
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast CancerEileen E Parkes, Steven M Walker, Laura E Taggart, et al.
Pageof 4